Learned lots of details here which I never knew. IV atenolol has never had much buy-in in my 21 years at a large Canadian community hospital (and I don’t recall much uptake while I was a trainee either). Even IV metoprolol is now falling out of favour, although early oral beta blockade remains ensconced in our pattern of practice. Look forward to the final summary of evidence for BB in the post MI non HF space.
This is very useful for a cardiology resident, especially since it comes in bits, it is not overwhelming, and you have the time to catch up and reflect. The audio feature is great also.
I hope that this series will advance my knowledge on the trials that got us where we are now in terms of clinical practice. It is information that can be easily skipped throughout training, but still very important. I am very grateful for this!
Please compare this trial with trial done using IV Metoprolol in patients with AMI. Finally give your opinion. Are the results still relevant in the contemporary practice?
This is great. Getting some really nice context from this as a cardiology fellow. I really hope that the posts will be laid out as a ‘series’ on a given therapeutic practice that we make, and culminates in the most recent evidence or even a final summary of the evidence for a practice (eg, beta blockers post MI). That would be incredibly useful for all practicing cardiologists.
Learned lots of details here which I never knew. IV atenolol has never had much buy-in in my 21 years at a large Canadian community hospital (and I don’t recall much uptake while I was a trainee either). Even IV metoprolol is now falling out of favour, although early oral beta blockade remains ensconced in our pattern of practice. Look forward to the final summary of evidence for BB in the post MI non HF space.
This is very useful for a cardiology resident, especially since it comes in bits, it is not overwhelming, and you have the time to catch up and reflect. The audio feature is great also.
I hope that this series will advance my knowledge on the trials that got us where we are now in terms of clinical practice. It is information that can be easily skipped throughout training, but still very important. I am very grateful for this!
Please compare this trial with trial done using IV Metoprolol in patients with AMI. Finally give your opinion. Are the results still relevant in the contemporary practice?
This is great. Getting some really nice context from this as a cardiology fellow. I really hope that the posts will be laid out as a ‘series’ on a given therapeutic practice that we make, and culminates in the most recent evidence or even a final summary of the evidence for a practice (eg, beta blockers post MI). That would be incredibly useful for all practicing cardiologists.